Treating to the Latest Evidence, A Collaborative Approach to Clinical Decision Support

ACEP, USACS, and BWH briefly share how each of their organizations has responded to the COVID-19 pandemic.

The evidence supporting the triage and treatment of COVID-19 is changing minute-by-minute. Keeping current is challenging, if not impossible, in the face of a pandemic. Technology plays a role in providing access and scale to a widening pool of information, creating the ability to rapidly share the latest information and guidelines. The Collaborative Clinical Advisory Committee (CCAC) is a consortium of healthcare industry leaders gathered by EvidenceCare, ACEP, Elsevier, DynaMed, and CUCM in response to the COVID-19 pandemic. The consortium created and launched a collaborative CDSS solution for COVID-19 and has created a series of webinar events for leaders across the industry to discuss and review new findings, approaches, and solutions as they become available. Today, the crisis is COVID-19; tomorrow might present something new. During this inaugural session, listeners will be introduced to the team, including leaders from ACEP, USACS, and Brigham and Women’s Hospital.


Featured Panelists:

Dr. Sandra Schneider

Associate Executive Director for Clinical Affairs, ACEP

Dr. Amer Aldeen

Chief Medical Officer, US Acute Care Solutions

Dr. Hasan Siddiqi

Senior Cardiovascular Disease and Research Fellow, Brigham and Women's Hospital/Harvard Medical School

Dr. Brian Fengler

Chief Executive Officer, EvidenceCare


To view this webinar on-demand, please complete the form: